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The interaction of the respiratory syncytial virus (RSV) Matrix (M) protein with the plasma membrane was investigated
using polyclonal and monoclonal antisera raised against recombinant M expressed in bacteria. M bound mainly to the plasma
membrane, although a significant proportion bound to internal membranes. However, no localisation of M with the Golgi was
observed, suggesting that transport of M to the plasma membrane was independent of the transport mechanism for the viral
glycoproteins. Expression from a recombinant baculovirus demonstrated the ability of M to bind membranes in the absence
of viral glycoprotein expression. When cell-surface expression of the viral glycoproteins was prevented using Brefeldin A, M
was still found in association with the plasma membrane, but the characteristics of M’s membrane-binding ability were
different to that found in untreated infected cells. In the presence of normal glycoprotein expression, M was sorted into lipid
rafts and, in addition, formed structures that could only be disrupted by treatment with high salt buffers, a feature suggesting
an interaction with the cytoskeleton or the formation of strong intramolecular associations. Brefeldin A prevented M from
being sorted into lipid rafts or from forming strong intramolecular associations. Brefeldin A also affected the stability of M
bound to the plasma membrane, as M was more readily dissociated in the presence of the inhibitor. Coexpression of M and
F resulted in the incorporation of M into lipid rafts but did not cause the formation of the strong intramolecular bonds,INTRODUCTION
Respiratory syncytial virus (RSV) is the prototype mem-
ber of the Pneumovirinae, a subfamily of the Paramyxo-
viridae. This group of viruses, along with the Rhabdoviri-
dae, Bornoviridae, and Filoviridae, form the Mononega-
virales superfamily. Paramyxoviridae virions have a
membrane derived from the host cell that is embedded
with viral glycoproteins that mediate cell attachment and
fusion to the target cell to initiate infection. Within the
virion, the major structural element is the nucleocapsid,
a helical structure containing the RNA genome tightly
bound by Nucleocapsid (N) protein. Underlying the viral
membrane, and possibly in contact with the nucleocap-
sid, is the Matrix (M) protein, possibly the most abundant
viral protein in the virion. The M protein does not pene-
trate through the lipid bilayer but coats it as a protein-
aceous layer on the inner face. Work on a number of
viruses has demonstrated the intrinsic ability of M pro-
teins to bind to membranes and artificial lipid vesicles.
This association, while undoubtedly requiring some de-
gree of hydrophobicity on the part of M, appears to be
largely due to the attraction of electrostatic charges on
1© 2002 Elsevier Science (USA)
All rights reserved.the membrane and M (Faaberg and Peeples, 1988;
Ruigrok et al., 2000b).
Mononegaviruses bud from the plasma membrane
and it is thought that the interaction between the glyco-
proteins, M, and the nucleocapsid is important for this
process. Recently Coronel et al. (2001) demonstrated that
the M protein of human parainfluenza virus type 1 was
able to specifically incorporate helical nucleocapsids
into virus-like particles that budded into the cell medium.
An interaction between M and the glycoproteins for
some members of the Paramyxoviridae has been dem-
onstrated, but where this interaction initially occurs is not
clear. The M of Newcastle disease virus (NDV) associ-
ated with the viral glycoproteins at the plasma mem-
brane. Inhibition of glycoprotein transport, using monen-
sin, prevented plasma membrane association; the M did
not associate with viral glycoproteins that were retained
on internal membranes (Yoshida et al., 1986). Sanderson
et al. (1993) demonstrated an interaction between Sendai
virus (SV) M with the viral glycoproteins while they were
in transit through the secretory pathway (i.e., the M could
be detected on the Golgi) and these authors showed that
the presence of the viral glycoproteins was required for
M protein’s membrane-binding ability. This was disputed
by Stricker et al. (1994), who suggested that the SV Msuggesting that additional factors are required for this phe
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viral glycoproteins occurred later, possibly at the plasma
membrane. Stricker et al. (1994) showed that SV M could
bind membranes intrinsically but that the glycoproteins
were necessary for the stable association of M with the
plasma membrane. Recent work on measles virus (MV)
demonstrated that its M could target the apical plasma
membrane independently of the glycoproteins. There
was evidence for an interaction between the MV M and
Fusion (F) protein on intracellular membranes since M
was involved in the retargeting of F from the basolateral
membrane to the apical membrane, which would appear
to suggest that M was the major regulator of MV assem-
bly (Naim et al., 2000).
In this article, we describe the association of the RSV
M protein with the plasma membrane. We show that the
M’s membrane binding is stabilised by the surface ex-
pression of the viral glycoproteins and that F appears to
pull M into detergent-resistant structures, such as lipid
rafts.
RESULTS AND DISCUSSION
Localisation of RSV M protein in infected cells
Little information is available on the intracellular dis-
tribution of the RSV M and its association with mem-
branes and the viral glycoproteins. To undertake such
studies, monoclonal antibodies (Mabs) were raised
against recombinant M protein that was purified from
bacteria (not shown) and a rabbit polyclonal, RPM01,
was raised against the amino-terminus of the M protein
(amino acids 1–157), also expressed in bacteria. The
specificity of these reagents was tested in a number of
immunological assays (such as RIPA, ELISA, and West-
ern blotting) using RSV-infected cells as antigen. A Mab
(M24) was found to be reactive against RSV M in all
assays and was used, in conjunction with the polyclonal
antisera, for the work presented here.
When the pattern of M staining in RSV infected cells
was visualised by confocal immunofluorescence (IF) mi-
croscopy, M could be observed staining within the cy-
tosol and in protrusions that extend from the plasma
membrane (Fig. 1a, arrow). These structures are formed
by actin polymerisation induced by the virus infection
and have been observed before (Burke et al., 1998; Prin-
gle et al., 1981; Ulloa et al., 1998; G. Henderson, J. Murray,
and R. P. Yeo, unpublished observations). By analogy
with influenza virus and human parainfluenza virus type
2, these structures are considered to be filamentous
forms of the virus (Roberts et al., 1998; Yao and Compans,
2000) and are probably involved in cell–cell spread or
represent a mechanism for viral dissemination within a
mucoid environment such as the lung. When cells were
counterstained for the F protein, we observed colocal-
isation with M around the periphery of the cell but no
significant internal colocalisation (Fig. 1b), unlike the
situation with MV and SV where their Ms were found to
localise with F, notably in the Golgi apparatus (Naim et
al., 2000; Sanderson et al., 1993). A perinuclear region,
presumably the Golgi, stained heavily with the F but
apparently excluded the M. This was more clearly seen
when infected cells were counterstained with WGA, a
marker for the Golgi (Fig. 2a). When a triple-labeled
sample (Fig. 2e) was split into its constituent colours, we
observed that WGA and F colocalised, and we noted that
both stained a perinuclear region of the cell, reminiscent
of the Golgi (Fig. 2g). The M polyclonal, however, stained
the cytoplasm in a more diffuse manner (Fig. 2b) with no
obvious localisation to a perinuclear region. In Fig. 2d (M
 WGA) and Fig. 2f (M  F) no specific colocalisation
was apparent internally, any overlaps observed coming
from the diffuse, and intense, staining of the cytoplasm
by the M Mab. It was only on the viral filaments (seen
clearly in Fig. 2c) that significant colocalisation could be
discerned between M and F. These results suggest that
RSV M does not ultilise the glycoprotein transport path-
way to target the plasma membrane but rather, as de-
scribed by Stricker et al. (1994) for SV, the RSV M utilises
an, as yet, unknown pathway. If this is a correct assump-
tion, then inhibiting glycoprotein transport should not
affect the M’s ability to target the plasma membrane.
Infected cells treated with Brefeldin A, and with cyclo-
heximide to prevent protein synthesis were visualised by
IF (Figs. 2h–2j). Whereas the F was retained internally
(Fig. 2h), possibly within the endoplasmic reticulum, an
accumulation of M under the plasma membrane was
observed (Fig. 2j). Some M was found internally with the
F but mainly appeared to have associated with the
plasma membrane, or at least accumulated under it.
Cells treated with Brefeldin A had a rounded appearance
due to the cytotoxic effects of the inhibitor and also
lacked the viral filaments, suggesting that inhibition of
glycoprotein expression affects filament formation. Ear-
lier observations have shown that infection by RSV tem-
perature-sensitive mutants (for example, in the M or G
proteins) at nonpermissive temperatures, or chemical
inhibition of the cleavage of F, also prevented formation
of viral filaments (Pringle et al., 1981; Sugrue et al., 2001).
Thus, formation of the viral filaments is a complex pro-
cess requiring concurrent viral assembly.
Sucrose flotation gradients were used to test whether
M binds membranes after Brefeldin A treatment. RSV-
infected A549 cells, treated or untreated with Brefeldin A,
were lysed in HLB and plasma membranes separated
from internal membranes and soluble protein. The sep-
arated fractions were subjected to sucrose flotation cen-
trifugation and analysed by Western blot (Fig. 3a) fol-
lowed by densitometry (Table 1). M in untreated samples
was bound to both plasma and internal membranes; a
small percentage of the total (20%) was present as
soluble protein at the bottom of the gradients. The ma-
jority of M was found bound to membranes, primarily the
plasma membrane (ca. 55%, see Table 1), which sug-
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gests a preference over binding to internal membranes
(ca. 26%). When cells were treated with Brefeldin A, the
M was still able to bind plasma and internal membranes
but the majority of the M (ca. 70%) was found as soluble
protein (Table 1). When the distribution of M from plasma
membranes from cells treated with Brefeldin A was com-
pared to that of untreated controls, there was a signifi-
cant increase in the amount of M found in the bottom
fractions of the gradients (18% compared to 1%). To
ensure that the M obtained from the plasma membrane
fraction was not contaminated with soluble M from the
initial extraction, the plasma membranes were washed
twice before flotation analysis. We suggest that the in-
crease in the amount of soluble protein observed repre-
sents M previously bound to the plasma membrane but
whose association is disrupted by the centrifugation
through the sucrose gradient. In the absence of viral
glycoproteins, it appears that M is more likely to disso-
ciate. However, it is clear that while surface expression
of the glycoproteins affects M’s membrane-binding abil-
FIG. 1. IFA of M and colocalisation with F. (a) RSV-infected A549 cells were fixed with formaldehyde and acetone and probed with the M polyclonal,
RPM01, and detected with anti-rabbit FITC. Note the diffuse cytoplasmic staining and the staining of the viral filaments (arrowed) by M. (b)
Colocalisation of M and F occurs at the cell periphery. M was detected using RPM01, whereas the F was detected using a mouse anti-F Mab. The
rabbit antibody was detected using an anti-rabbit FITC conjugate (green) and the anti-F with an anti-mouse Cy5 conjugate (red). The only significant
colocalisation appears to be on the periphery of the cell. Note that a perinuclear region of the cell, probably the Golgi, stains specifically for the F
but not for M.
FIG. 2. (a–g) The M of RSV does not accumulate on the Golgi. RSV-infected A549 cells were fixed with formaldehyde and acetone. The cells were
stained for M using the rabbit polyclonal followed by anti-rabbit Cy3 (blue channel) and for F using the mouse Mab that was detected by anti-mouse
Cy5 (red channel). To visualise the Golgi apparatus WGA conjugated to FITC (green channel) was used. A representative image (e) was processed
by splitting the channels into their component colors and remixing the channels using Adobe Photoshop by omitting one or two of the individual color
channels to produce dual or single colored images. (a) WGA (green); (b) M (blue); (c) F (red); (d) M  WGA (blue  green); (e) M  F  WGA (blue
 red  green); (f) M  F (blue  red); (g) F  WGA (red  green). (h–j) Effect of Brefeldin on the distribution of M and F. A549 cells were infected
for 3 h before the addition of Brefeldin A for a further 16 h, 2 h before fixation cycloheximide was added; the cells were fixed as above and stained
for F and M. (h) F; (i) Merge (F M); (j) M.
FIG. 3. (a) Effect of Brefeldin A on M’s membrane binding ability as determined by membrane flotation gradients. A549 cells were infected with RSV
for 3 h before the addition of Brefeldin A. Infections were also performed in the absence of the inhibitor. Plasma membranes were separated from
soluble protein and internal membranes by centrifugation. Plasma membranes and internal fractions were analysed by sucrose flotation gradients
which were fractionated from the top (10% sucrose) to the bottom (70% sucrose), followed by Western blot analysis using the M Mab (M024). The
expected positions of membrane-bound and soluble protein are indicated. The bands were subjected to densitometry (see Table 1) using Bio-Rad
Quantity One software. (b) Effect of Brefeldin A on F proteins plasma membrane expression. Plasma membrane fractions isolated from sucrose
flotation gradient, from equivalent numbers of cells either untreated (band 1) or treated (band 2) with Brefeldin A. The level of F into treated sample
is severely reduced. (c) M expressed from recombinant a baculovirus (Bac-M) can bind membranes in the absence of the viral glycoproteins. Sf21
cells were infected at a multiplicity of 5 for 72 h before the cells were treated as above. The membrane containing fractions were pooled and analysed
by Western blot using an M024. Both the plasma and the internal membranes bind baculovirus expressed M. Lane 1, RSV infected cell lysate; Lane
2, blank; Lane 3, plasma membrane from Bac-M-infected Sf21 cells; Lane 4, internal membranes from Bac-M infected Sf21 cells.
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ity, plasma membrane binding of M can occur in the
absence of the glycoproteins. To ensure that the binding
was not due to a portion of F expressed on the surface
after Brefeldin treatment, the total plasma membrane
preparation (approximately 107 cells) was tested for F by
Western blot. F was barely detectable on plasma mem-
branes obtained after Brefeldin treatment (Fig. 3b) and it
is unlikely that this level of surface expression can ac-
count for the amount of M bound to the plasma mem-
brane.
The ability of M to bind membranes in the absence of
other viral proteins was tested by expression in non-
mammalian cells using a recombinant baculovirus. Sf21
cells were infected with Bac-M for 72 h. The plasma and
internal membranes were separated and fractionated on
sucrose gradients. The fractions containing the mem-
branes were analysed by Western blotting, and M was
detected on both plasma and internal membranes (Fig.
3c, Lanes 3 and 4). Thus, M does not require F, or indeed
any other viral protein, for membrane association and is
consistent with the observation that purified M proteins
from influenza and Ebola viruses have previously been
shown to bind to artificial lipid bilayers without the pres-
ence of viral glycoproteins (Ruigrok et al., 2000a,b).
The M is sorted into detergent-insoluble structures
by the glycoproteins
As pointed out in the previous section, and as shown
in Fig. 2, M and F colocalised at distinct membrane
structures on the cell surface. We observed that the F
and M Mabs specifically stained the viral filaments and
generally speaking the intervening membrane was de-
void of these proteins. The presence of N, P, and M2-1
could also be shown to be incorporated into the fila-
ments (not shown), suggesting that they were sites of
viral assembly. The selective staining of the membrane
component of the filaments, and the lack of staining of
the intervening plasma membrane, suggested that there
may be some feature unique to the viral filaments that
promoted association with viral components. One possi-
bility is the occurrence of lipid rafts, a particular mem-
brane form that is rich in glycosphingolipid and choles-
terol and is characterized by insolubility in a nonionic
detergent (Triton X-100) at low temperature (Ahmed et al.,
1997; Schroeder et al., 1998). Such detergent-resistant
membranes (DRMs) or lipid rafts, originally identified as
components of caveolae, are involved in the sorting of
membrane proteins from the Golgi to the apical mem-
branes (Keller and Simons, 1998) and serve as regions of
the plasma membrane involved in the transfer of cell
signals from the surface to the actin cytoskeleton. The
various forms of lipid rafts and their functionality have
been reviewed by Simons and Toomre (2000). Lipid rafts
have been shown to be involved in the assembly of a
number of enveloped virus such as influenza, filoviruses,
MV and HIV-1 (Barman et al., 2001; Bavari et al., 2002;
Manie et al., 2000; Nguyen and Hildreth, 2000). These
specialized membrane domains may allow the coordi-
nated interaction of viral proteins during viral morpho-
genesis and favor budding from the plasma membrane.
The involvement of lipid rafts in RSV assembly was
tested by treating whole-cell extracts with Triton X-100 or
octylglucoside (which destroys lipid rafts) and separating
the products on sucrose flotation gradients. With Triton
X-100, significant proportions of F and M were found in
low-density sucrose fractions, which would be expected
if they had sorted into DRMs (Fig. 4). CD55, a known lipid
raft protein (Friedrichson and Kurzchalia, 1998), was
found almost wholly at the top of the gradients after
Triton X-100 treatment, whereas CD46, a nonlipid raft
protein (Manie et al., 2000), was only found in the lower
fractions, indicating that it was solubilised by such treat-
ment. After treatment with octylglucoside, however, M
and F were found almost exclusively in the higher den-
sity, non-membrane-associated fractions. Thus RSV, sim-
ilar to MV (Manie et al., 2000), may utilise lipid rafts
during assembly. Gower and Graham (2001) have dem-
onstrated that Lovastatin, which is known to disrupt the
formation of lipid rafts by inhibiting cholesterol synthesis,
prevented RSV replication and cell-to-cell fusion. The
mode of action of Lovastatin was not defined by Gower
and Graham (2001) but, taken together with the data
presented within this study, would indicate an role for
lipid rafts during RSV assembly.
The M forms strong ionic bonds at the plasma
membrane
An interesting observation regarding M was made in
experiments that employed IF to analyse the effect of
detergent extraction. When infected cells were treated
with detergents, before fixation, the pattern of F staining
TABLE 1
Effect of Brefeldin A on the Distribution of M
as Determined by Densitometry
Fraction Brefeldin A
Membrane
bound Soluble
   
Plasma membrane 55 19 1 18
Internal membranes 26 11 18 52
Note. The Western blots presented in Fig. 3a were digitalised using
a CCD camera system and densitometry performed using Bio-Rad
Quantity One software. The values represent the percentage of the total
M content (i.e., the total from the plasma membrane fraction and the
internal membrane fraction) found with and without Brefeldin A treat-
ment. The membrane-bound value represents M found at the top of the
sucrose flotation gradients (usually the top two fractions) and the
soluble fraction from M found at the bottom of the gradients (usually the
bottom four fractions).
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was as would be predicted from the flotation experi-
ments. That is, F remained bound to the cell surface after
Triton X-100 extraction but was completely removed by
octylglucoside (Fig. 5, top panels). However, M, while
being resistant to Triton X-100 extraction as expected,
was also retained after octylglucoside treatment (Fig. 5,
bottom panels). This phenomenon is reminiscent of an
association with the cytoskeleton; stability to octylglu-
coside results from strong ionic, protein–protein interac-
tions that the detergent is unable to disrupt. Serial sec-
tions of cells treated with either detergent showed that
the staining was located exclusively on the plasma mem-
brane; internal staining of M and F was largely removed
by either detergent, suggesting that the lipid raft associ-
ation occurs at the plasma membrane (not shown). This
possibility was tested using a modified flotation assay.
Plasma membranes from infected cells were isolated
from sucrose flotation gradients, pelleted, and resus-
pended in TNEO buffer. The samples were again centri-
fuged and the supernatant (soluble protein) and pellet
(insoluble protein) were analysed by Western blot. In
agreement with the IF data, the M remained insoluble
(Fig. 6a) after octylglucoside extraction. To test the as-
sumption that the octylglucoside-resistant form of M re-
sulted from protein–protein interactions, isolated mem-
branes were treated with octylglucoside in TNE contain-
ing 1 M NaCl, instead of the usual 150 mM, to disrupt
ionic interactions. M that had been associated with the
plasma membrane was largely solubilised after octylglu-
coside treatment in the high salt buffer (Fig. 6a). A similar
analysis of M bound to internal membranes showed that
M had not acquired detergent insolubility even under low
salt conditions (Fig. 6a). Plasma membranes isolated
after treatment of infected cells with Brefeldin A also
showed that M under these conditions had not acquired
resistance to either Triton X-100 or octylglucoside (Fig.
6b). Thus the association of M and lipid rafts (as typified
by membrane flotation after Triton X-100 treatment), and
the formation of the insoluble octylglucoside complex,
were dependent on surface expression of the glycopro-
teins.
If the M acquires resistance to octylglucoside due to
an association with a component of the cell cytoskeleton,
then it may be possible to coprecipitate such a candidate
protein with M. RSV-infected cells were chilled, washed
with TNE, and then extracted with TNEX for 30 min on
ice. The lysis solution was removed and retained. The
resultant cell “ghosts” were scraped into RIPA buffer and
both the supernatant (soluble protein) and the detergent-
resistant materials were precipitated by monoclonal and
polyclonal antibodies. Tests with a number of cytoskel-
eton Mabs were inconclusive mainly due to nonspecific
precipitation of actin (not shown). Previous reports have
implicated a role for actin, and indeed, there is an in-
crease in actin production and in RSV replication and it
has been shown that actin depolymerising agents, such
as Cytochalasin B, severely inhibit RSV viral production,
suggesting a role for actin in viral egress (Burke et al.,
1998; Ulloa et al., 1998; G. Henderson, J. Murray, and R. P.
Yeo, unpublished observations). A role for the actin cy-
toskeleton in virion assembly and morphology has been
suggested for a number of paramyxoviruses, and actin
was detected in paramyxovirus virion particles including
RSV (Bohn et al., 1986; Bose et al., 2001; Cowley and
FIG. 4. The F and M of RSV are found in association with detergent-resistant membranes, or lipid rafts. RSV-infected A549 cells were scraped into
TNE and washed. The cells were treated with either TNEX or TNEO for 30 min on ice. The lysates were subjected to flotation analysis on sucrose
gradients, fractionated, and probed with the antibodies to M and F. As controls antibodies against two cellular proteins, CD46 (nonlipid raft associated)
and CD55 (lipid raft associated), were also included to indicate where various fractions would migrate within this type of gradient. The expected
positions of membrane bound and soluble protein are indicated. Resistance to detergent treatment results in the appearance of protein at the top
of the gradient due to the proteins remaining associated with membranes. Soluble protein is found in the lower regions of the gradient.
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Barry, 1983; Giuffre et al., 1982; Gupta et al., 1998; Fernie
and Gerin, 1982). Involvement with the tubulin-based
microtubule array is unlikely since the detergent treat-
ments employed in this study were carried out at 0°C,
which induces depolymerisation of the microtubule array
such that components that interacted with this structure
would be rendered soluble by detergent extraction. If the
M does not associate with the cytoskeleton to form the
detergent-resistant structures in Fig. 5, it may be that the
observed resistance derives from protein–protein inter-
actions between molecules of M at the membrane. Self-
association of M proteins has been reported for a num-
ber of viruses and it is possible that the RSV M forms a
proteinaceous layer that is highly stable and resistant to
detergent extraction. In the course of these studies, the
purification of recombinant RSV M from bacteria was
undertaken, primarily as a source of antigen for mono-
clonal antibody production. We noted that recombinant
M precipitated when dialysed into PBS and concen-
trated, and that treatment with 1 M NaCl resulted in the
resolubilisation of the protein. This phenomenon has
been observed for M purified from other viruses. Initially
thought to be nonspecific aggregation, it is now known
that this represents spontaneous oligomerisation of the
M proteins (Gaudin et al., 1995, 1997; Heggeness et al.,
1982).
The F can pull M into lipid rafts but does not form
the strong ionic bounds
From the observations of Teng and Collins (1998) who
determined the minimal requirements for RSV infectious
particle formation (the nucleocapsid, M and F), and the
fact that viruses without G or SH have been isolated
(Karron et al., 1997), it is likely that F is the major inter-
acting partner with M catalysing these events. We tested
FIG. 5. Immunofluorescence of RSV-infected cells treated with detergents. A549 cells infected with RSV for 16 h were either left untreated and fixed
directly with formaldehyde and acetone, or treated with detergent for 30 min on ice, washed, and then fixed. The cells were then probed for the
presence of F or M using the appropriate Mab. Note that Triton X-100 hardly affects the surface expression of the F and M, but that octylglucoside
removes the F but not the M.
FIG. 6. Effect of high salt or Brefeldin A on the solubility of membrane
bound M. (a) Plasma or internal membranes were isolated on sucrose
flotation gradients, pelleted, and resuspended in TNEO with either 0.15
or 1 M NaCl. The treated membranes were centrifuged and the pellets
(P) and solubilised (S) fractions were analysed by Western blot using
the anti-M Mab M024. (b) Plasma and internal membranes, isolated
from RSV-infected cells exposed to Brefeldin A, were treated with TNEO
(with 150 mM NaCl) before centrifugation and analysis of the pellets (P)
and solubilised (S) fractions.
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the ability of M to enter lipids rafts in the presence or
absence of F using recombinant vaccinia viruses (vvM
and vvF, respectively). A549 cells were infected with
recombinant viruses expressing M, F, or both, and the
plasma membranes isolated on sucrose flotation gradi-
ents. The membranes were subsequently treated with
either Triton X-100 or octylglucoside and pelleted as for
the Brefeldin experiment. Both the pellet (lipid rafts) and
the soluble fractions were tested by Western blot analy-
sis. The occurrence of M, when expressed alone, within
these samples confirms the observation with baculovi-
rus-expressed M that it is able to bind membranes in the
absence of other RSV proteins and will do so in mam-
malian cells. F when expressed by itself was found in the
pelleted fraction after Triton X-100 extraction (Fig. 7a),
suggesting that it was able to associate with lipid rafts
independently of other viral proteins. M, when expressed
alone, was found exclusively within the soluble fraction
(Fig. 7b); however, when coexpressed with F, we found
that a proportion of M was present in the pelleted frac-
tion after Triton X-100 treatment. Thus F affects M’s
membrane location. However, we also tested for the
formation of the strong intramolecular bounds formed by
M observed in RSV-infected cells. If they did form, then
we would expect M to pellet in the presence of octylglu-
coside. Surprisingly, although M when coexpressed with
F sorted into a Triton X-100-insoluble fraction that could
be pelleted, we found no evidence for the conversion to
a octylglucoside-resistant form at the plasma membrane.
We have no evidence that coexpression of M with G, or
M with N, results in the formation of the octylglucoside-
resistant form of M (R. P. Yeo, unpublished observations).
It may be that this phenomena requires a number of
permeations found only in RSV-infected cells.
The data presented here are inconsistent with a strat-
egy for M’s migration to the plasma membrane via the
glycoprotein mass transport system, as proposed for SV
by Sanderson et al. (1993). Our observations are akin to
those of Stricker et al. (1994), who reported that SV M
bound the membrane, without the influence of the glyco-
proteins, but that an interaction with F resulted in the
concentration and localised oligomerisation of the M
under the membrane. Mottet et al. (1999) demonstrated
that the SV M could bind membranes intrinsically but,
similar to the observations here, the membrane binding
was stabilised by other viral factors. It is evident from our
data that a similar phenomenon occurs for RSV, as
shown by the acquisition of detergent resistance when
the F was expressed on the cell surface. Whether the
enhanced membrane binding by RSV M is due to the
direct interaction of the M with the glycoproteins (or
other viral proteins), or due to the suggested oligomeri-
sation of M, is not presently known.
We propose the following events as part of the path-
way of viral assembly prior to budding of the virion. M,
produced initially as a soluble protein, associates with
membranes directly and this interaction, in the absence
of viral glycoproteins, may be transient and M may be
able to dissociate readily. When the glycoproteins are
present on the plasma membrane (after proper process-
ing and transport, etc.), the M’s binding to the plasma
membrane stabilises. The glycoproteins, or at least the F,
are sorted into lipid rafts, as suggested for MV (Manie et
al., 2000), which affects the cellular location of M. The
questions to be addressed in light of this article are
whether or not the remaining glycoproteins sort indepen-
dently into lipid rafts or, similar to M, require the pres-
ence of F, and what is the role of the nucleocapsid in M’s
functionality. Evidence for a role of the SV and MV nu-
cleocapsids in M functionality has been demonstrated by
Stricker et al. (1994) and Vincent et al. (2000), respec-
tively.
To summarise, we have shown that the M has an
intrinsic membrane binding ability that does not depend
on association with the viral glycoproteins. The M can
interact with the plasma membrane even when the gly-
coproteins are prevented from surface expression. How-
ever, such an association is responsible for the sorting of
M into lipid rafts and for stabilising the M’s membrane
association. The M has a resistance to detergents that is
independent of that derived from associating with lipid
rafts. A strong protein–protein interaction occurs that is
disrupted by high salt concentrations, which may indi-
cate an interaction with the cytoskeleton or by the self-
association of M at the plasma membrane.
MATERIALS AND METHODS
Cells, viruses, and glycoprotein expression inhibition
The human alveolar cell-line A549 was obtained from
the ATCC and maintained in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% (v/v) fetal calf serum
FIG. 7. The F pulls M into lipid rafts. A549 cells were infected with the
indicated vaccinia recombinants at an m.o.i. of 5 for 16–20 h and
plasma membranes isolated on sucrose flotation gradients before
treatment with either Triton X-100 or octylglucoside which were sub-
sequently pelleted. The pelleted (P), representing lipid rafts, and solu-
bilised (S) fractions were analysed by Western blot using either the
anti-F Mab (a) or the anti-M Mab (B). F acts as lipid raft protein would
be expected to, while M is only found in a Triton X-100-resistant form in
the presence of F. However, unlike the viral situation M is not converted
into a octylglucoside-resistant form when coexpressed with F.
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(Gibco). The A2 strain of RSV was used throughout this
study. Stocks were prepared in A549 cells by infecting at
a low m.o.i. (0.1) and maintaining infected cell cultures
in DMEM containing 2% (v/v) fetal calf serum at 33°C. For
immunofluorescence assays 13-mm-diameter coverslips
were seeded with A549 cells and infected at an m.o.i. of
1.0 for 16–18 h before fixation or detergent treatment (see
below). For membrane association studies, A549 cells in
T180 flasks were infected at an m.o.i. of 1.0 for 24–30 h
before analysis. Brefeldin A was used at a final concen-
tration of 100 g/ml. The inhibitor was added 3 to 4 h
postinfection and maintained for a further 26 h. Cyclo-
heximide, when used, was added at a final concentration
of 10 g/ml for 3 h prior to the termination of the infec-
tion. Recombinant vaccinia viruses expressing RSV F
protein (vvF) or M protein (vvM) were a gift from G. Wertz
(University of Birmingham, AL) and used at m.o.i.’s indi-
cated in figure legend.
Sf21 cells, for baculovirus expression, were main-
tained in TC100 medium (Gibco) with 10% FCS at 28°C.
Sf21 cultures were infected with the M expressing bac-
ulovirus (Bac-M) at an m.o.i. of 5 for 72 h before harvest-
ing.
Antibodies
The mouse Mab to the F (Mab 19) was a kind gift from
G. Taylor (Institute of Animal Health, Compton, U.K.). The
M Mab used in this study, M024, was produced by
immunising BALB/c mice with a recombinant M protein,
containing a histidine tag, produced and purified from
Escherichia coli. The M polyclonal (RPM01) was pro-
duced in rabbits immunised with a carboxyl-terminal
truncated M fused to GST. The GST M protein was
purified by SDS–PAGE and isolated by electroelution
before use as an immunogen. Both the M Mabs and the
M polyclonal were tested for specificity in ELISA, immu-
nofluorescence, immunoprecipitation, and Western blot
analysis against infected and mock-infected cells (re-
sults not shown). Antibodies to CD46 and CD55 were
gifts from D. Evans and I. Goodfellow (University of Glas-
gow, U.K.).
Baculovirus construction
A baculovirus expressing the M protein of RSV was
produced by isolating the M ORF by RT PCR of RNA from
infected cell cultures. The M fragment was cloned into
pcDNA3.1 (Invitrogen) and sequenced. A mutation that
resulted in a 1 frameshift was corrected by in vitro
mutagenesis; the final amino acid sequence is identical
to that in the GenBank database (M74568). The corrected
M fragment was subcloned into the pFastbac-1 vector
(Invitrogen) and subsequently used to prepare recombi-
nant baculoviruses using the Fastbac kit as described in
the manufacturer’s instructions (Invitrogen). Viruses were
screened for protein production by Western blot of in-
fected cell lysates using the M Mab. A recombinant virus
was isolated (designated Bac-M), and stocks were pre-
pared in Sf21 cells.
Membrane fractionation analysis
A549 cells were infected with RSV at an m.o.i. of 1.0 for
24 h in the presence or absence of Brefeldin A. The cells
were dislodged by scraping into PBS, pelleted at 1000 g,
washed in hypotonic lysis buffer (HLB, 10 mM Tris pH 7.5,
10 mM MgCl2, 5 mM CaCl2), and pelleted again. The
volume of the pellet was estimated by eye and resus-
pended in an approximately equivalent volume of HLB.
After 15 min on ice, the cells were disrupted by vigorous
repeated passage through a G21 syringe needle. Nuclei
and heavy cell debris were pelleted at 100 g for 5 min.
Plasma membranes were isolated by pelleting the post-
nuclear extract at 1500 g in a TLA 100.2 rotor; the super-
natant (internal membranes and soluble protein) was
retained and the pellet (plasma membrane) was washed
twice with HLB to remove contaminating soluble protein
before being resuspended with low salt buffer (LSB, 50
mM Tris pH 7.5, 25 mM KCl, 5 mM MgCl2) in the initial
volume of the postnuclear extract. To 0.5 ml of membrane
fraction, 3.5 ml of 70% (w/v) sucrose in LSB was added
with thorough mixing. This was placed in the bottom of a
13-ml centrifuge tube, overlaid sequentially with 55%
(w/v) sucrose and 10% (w/v) sucrose. The gradient was
centrifuged for 16 h at 4°C in a TH641 rotor (Sorvall) at
250,000 g, fractionated into 1-ml aliquots, and analysed
directly by Western blot. Membranes, which were found
in the upper, low density fractions of the gradients were
diluted in LSB buffer to a final volume of 5 ml and
pelleted in an AH650 rotor at 250,000 g for 2 h at 4°C.
Membranes were resuspended in TNE (50 mM Tris pH
7.4, 150 mM NaCl, 2 mM EDTA) buffer and subjected to
detergent treatment (see below). For Bac-M expression,
the infected Sf21 cells were pelleted and treated as
above.
Detergent extraction
To analyse lipid raft involvement, cells were extracted
with detergents, as described by Manie´ et al. (2000),
before flotation on sucrose gradients. Briefly, infected
cell monolayers were scraped into and washed with cold
TNE buffer before being suspended in 0.5 ml of TNE with
1% (v/v) Triton X-100 (TNEX) or 60 mM octyl--glucoside
(TNEO) on ice for 30 min. The extracts were clarified by
centrifugation at 100 g and the lysate (total membrane)
was subjected to sucrose flotation as above. Alterna-
tively, membranes previously isolated on sucrose flota-
tion gradients, as described above, were treated with
detergents by adding an equal volume of TNE with 2%
(v/v) Triton X-100 or 120 mM octyl--glucoside and incu-
bating on ice for 30 min. For protein–protein interactions
the membranes were treated with TNEO containing 1 M
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NaCl. The treated membranes were pelleted at 15,000 g
in a TLA 100.2 rotor (Beckman) for 20 min, and the pellet
and supernatant were prepared for PAGE and subse-
quent Western blotting.
Western blotting and densitometry
Membrane fractions were separated by 12% SDS–
PAGE and transferred to nitrocellulose. After blocking,
the primary antibody was added for 1 h at room temper-
ature, followed by the appropriate antispecies HRP con-
jugate, again for 1 h. Bound antibody was detected by
ECL; the autoradiograms were digitised using a Bio-Rad
Fluor-S CCD camera system, and densitometry was per-
formed using Bio-Rad Quantity One software.
Immunofluorescence
RSV-infected or mock-infected cells were fixed using
3.7% formaldehyde followed by dehydration using ace-
tone. The coverslips were washed with PBS and the
primary antibodies added at a suitable dilution, in PBS,
for 1 h at room temperature. To visualise the Golgi
apparatus wheat germ agglutinin (WGA) was conjugated
to FITC (Molecular Probes), was used at a 1/100 dilution,
again in PBS. The coverslips were washed with PBS
before the addition of the appropriate antispecies sec-
ondary antibody conjugated to FITC (Sigma), Cy3, or Cy5
(Amersham) for 1 h at room temperature. After washing
off unbound conjugated antibody the coverslips were
mounted in Citifluor before visualisation using a Zeiss
LSM confocal microscope. For visualisation of detergent
extracted cells, cells on coverslips were cooled on ice,
washed with ice-cold TNE, and incubated with TNEX or
TNEO for 30 min on ice. Treated samples were washed
with TNE before fixation with 3.7% formaldehyde in PBS
and IF was performed as described above. Before re-
taining images, a number of optical slices were taken to
ensure that images were representative of the whole
cell. Settings were achieved to negate channel overlap
and images captured using the LSM510 software and
further manipulated using Adobe Photoshop.
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